It is well established that PDE4 inhibitors are anti-inflammatory drugs [15] and that PDE4 inhibitors are beneficial in nephropathy [18], suggesting that PDE4 inhibitors might be helpful for prevention and treatment of SLE. The gene discussed is PDE4A; the disease is systemic lupus erythematosus.